Brother's Keeper: Wild-Type Mutant K-Ras Dimers Limit Oncogenesis
- PMID: 29425486
- DOI: 10.1016/j.cell.2018.01.019
Brother's Keeper: Wild-Type Mutant K-Ras Dimers Limit Oncogenesis
Abstract
K-Ras is the undisputed champion of oncogenes, yet our ability to interfere with its oncogenic function is hampered by insufficient mechanistic understanding. In this issue of Cell, Ambrogio and colleagues connect the ability of K-Ras to dimerize to the ability of wild-type K-Ras to limit the oncogenic properties of the mutant.
Copyright © 2018 Elsevier Inc. All rights reserved.
Comment on
-
KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS.Cell. 2018 Feb 8;172(4):857-868.e15. doi: 10.1016/j.cell.2017.12.020. Epub 2018 Jan 11. Cell. 2018. PMID: 29336889
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
